Calculation and comparison of the model for end-stage liver disease (MELD) score in patients accepted for liver transplantation in 1999 and 2004

A Flodén; M Castedal; S Friman; M Olausson; L Backman

doi:10.1016/j.transproceed.2007.01.013

Calculation and comparison of the model for end-stage liver disease (MELD) score in patients accepted for liver transplantation in 1999 and 2004

Transplant Proc. 2007 Mar;39(2):385-6. doi: 10.1016/j.transproceed.2007.01.013.

Authors

A Flodén¹, M Castedal, S Friman, M Olausson, L Backman

Affiliation

¹ Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden. anne.floden@vgregion.se

PMID: 17362737
DOI: 10.1016/j.transproceed.2007.01.013

Abstract

There has been a need to assess the "sickness degree" in patients with acute and chronic hepatic failure. The Model for End-Stage Liver Disease (MELD) score was developed as a tool for a more objective estimate of the "degree" of sickness in patients with chronic liver disease. In this study, the MELD score was retrospectively calculated and compared in adult patients accepted for orthotopic liver transplantation (OLT) in our institution in 1999 and 2004. We analyzed the gender, age, and MELD score associated with different indications for OLT during this period.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Female
Humans
Liver Cirrhosis / surgery
Liver Failure / surgery*
Liver Neoplasms / surgery
Liver Transplantation / statistics & numerical data*
Male
Patient Selection*
Prognosis
Reoperation / statistics & numerical data
Retrospective Studies
Sweden